AG T​orrez announced that the State of New Mexico has reached a $2.25 million settlement with Mylan Inc., resolving claims that the pharmaceutical company engaged in unfair and anticompetitive practices related to its EpiPen Auto-Injector products. The agreement brings significant financial relief and consumer protections to New Mexico residents.

“This settlement serves as an important protection for New Mexico consumers and families who depend on affordable access to life-saving epinephrine products,” – AG Torrez